Hiv/Aids, Drug Use, and Highly Vulnerable Youth: Targeting Research Gaps

The summary for the Hiv/Aids, Drug Use, and Highly Vulnerable Youth: Targeting Research Gaps grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Hiv/Aids, Drug Use, and Highly Vulnerable Youth: Targeting Research Gaps: The National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH) invite innovative applications to address critical gaps in research on HIV/AIDS prevention, treatment, and related health issues among highly vulnerable youth. For the purpose of this RFA, highly vulnerable youth are those children, adolescents, and young adults aged 10-24 years who are using or are at high-risk for using drugs (both injection and non-injection drug use) and who are (a) at high risk for HIV and other infectious diseases (e.g., hepatitis B virus (HBV), hepatitis C virus (HCV), (b) living with HIV/AIDS, and/or (c) affected by HIV/AIDS (e.g., youth with family living with HIV, especially youth from drug-using households; youth bereaved by HIV, including youth orphaned by HIV/AIDS). This initiative is focused on highly vulnerable youth in the United States who are particularly vulnerable to HIV/AIDS and its medical and psychosocial consequences: (a) youth in risky social environments who are exposed to multiple factors associated with drug abuse and HIV, but who have limited exposure to factors that are protective, (b) youth who live outside of the protective influences of traditional family, school, or work venues (e.g., on the street, homeless and runaway youth, youth in foster care, incarcerated youth, youth in gangs, migrant youth), (c) youth who represent the current or emerging face of the HIV epidemic in the U.S. (e.g., young minority females, young men who have sex with men, youth from rural or suburban areas), and (d) youth in families and/or communities already vulnerable as a result of poverty, HIV/AIDS, drug abuse, mental illness, stigma, discrimination, and violence. The overall objective of this RFA is to facilitate the development and implementation of interventions that reduce HIV infections and mitigate the medical and psychosocial consequences of the virus in order to improve the health and quality of life of youth at risk for, living with, or affected by HIV/AIDS. This RFA encourages innovative, culturally relevant, and gender sensitive research in the following areas: (a) epidemiology of current and emerging trends related to HIV/AIDS and drug use patterns, physical and mental health comorbidities, and social environments among highly vulnerable youth; (b) development, implementation, evaluation, and dissemination of innovative approaches to prevent the transmission of HIV infection; (c) access to, receipt of, and adherence to health and drug abuse treatment services, including research on barriers to treatment such as stigma, and on optimizing HIV/AIDS risk reduction through drug abuse treatment; (d) integration of services (e.g., HIV/AIDS prevention and treatment services, HIV/AIDS medical services with drug abuse prevention and/or treatment, HIV/AIDS and HBV/HCV prevention).